Estimating the glomerular filtration rate in obese adult patients for drug dosing.
about
Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic reviewDosing of antibacterial agents in obese adults: does one size fit all?Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.Steady-state plasma pharmacokinetics of oral voriconazole in obese adults.A modest proposal for improving the accuracy of creatinine-based GFR-estimating equations.Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patientsFat-free weight prediction in morbidly obese females.Creatinine-based equations for the adjustment of drug dosage in an obese population.Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis.Accuracy of GFR estimation in obese patients.The effects of obesity on drug pharmacokinetics in humans.Vancomycin dosing and monitoring 2 years after the guidelines.Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician.Impact of obesity on drug metabolism and elimination in adults and children.Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.Pharmacologic prevention of venous thromboembolism in obese patients.Dosing considerations for obese patients receiving cancer chemotherapeutic agents.Antibiotic dosing in obesity: the search for optimum dosing strategies.Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis.Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Epidemiology of acute kidney injury in the intensive care unitComprehensive Guidance for Antibiotic Dosing in Obese Adults.Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial inPeak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.Drug therapy management in patients with renal impairment: how to use creatinine-based formulas in clinical practice.Antibiotic dosing in obesity: a BIG challenge.Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease.Changes in renal function following Roux-en-Y gastric bypass: a prospective study.Relationships of Vancomycin Pharmacokinetics to Body Size and Composition Using a Novel Pharmacomorphomic Approach Based on Medical Imaging.No role for patient body weight on renal function assessment for drug dosing.The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.Disagreement in Estimates of Kidney Function for Drug Dosing in Obese Inpatients.Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.Measurement of Skeletal Muscle Area Improves Estimation of Aminoglycoside Clearance Across Body Size.
P2860
Q28543876-49032F87-6CB7-4338-80B3-EA1016B75185Q30362353-D89B3E81-A92D-4737-80B2-4C1043083FD4Q30407250-57F5B8DF-C179-4D55-8897-F9862BA2CEA8Q33763123-2249C7F2-C3DD-4B71-9258-EF91DE8148ADQ35004898-CEE41A19-93C5-4681-9748-68C05A4D2E37Q35134724-B47DB2FC-6551-4F89-A4A3-94FF0BA65DAFQ35191383-D5B99B23-6200-42C6-B34D-0EE273FDD438Q35602586-B4CF1AE2-AF5C-4763-9341-8619DDF302E3Q36802097-3D781B67-8913-4F1D-B5A8-91E645B3ADE5Q36924693-071110FC-18CA-4E20-948A-208CCAF4A0D1Q37348394-7AEF3E93-3405-42E5-A74C-79463759EDAFQ37682222-E88BF13D-4F70-45E7-803D-433A4492BF91Q37854751-DD3DF447-6F96-4F63-88F3-2CA5D197E851Q37892556-F4F0F751-E35A-4D5A-A762-BA7EC39A66C9Q37970042-BAEC8EE2-BF5B-46B4-AF41-0CF8008A236BQ37997025-09D87D8F-0F74-4B87-9D12-621D4C28F2B2Q38019839-52B1C7A5-271C-4629-B135-68E0F7F4B7DBQ38062477-E0F4BA08-6C90-4E2A-84AB-C2709A496CB5Q38164666-44239800-E182-4324-8D48-5F6C661AD5BEQ38397264-812386F8-C1FE-444B-8C7A-B2BD9930C96CQ38697238-5F178728-5C44-47D4-A589-7E66DBD99E13Q38887625-FCCFBF41-FAE3-42A2-A020-7D48FD5F2B7CQ38959281-D0FAA507-BDA1-41B9-AF4B-DC0A7242465AQ39657598-5A953707-5BBA-478F-8951-D2745799DD70Q40067964-FB63E48C-C080-41B4-9E9F-A9E259B111EDQ41349399-C17A59FF-2A89-4429-A1FB-3A76C635645AQ41695499-4713325D-6E77-4B19-97E7-792E25C513EBQ41979166-DD33DBCB-15C7-45AF-A658-DEA0D60E9315Q42368757-5BF5BA15-928C-4A97-A67E-450877DFF04EQ44311698-A6944DA7-A2C4-4D24-A0E2-2CCF2DAA94D9Q44455948-6986EEF4-8C9E-4E7C-B9D8-C33A74F06A95Q45191658-4DCC6722-012B-4980-B785-0F9D7B2E5671Q45815953-B891BDF5-0E90-43AB-829E-A705B92F0A93Q46098575-ACF34BEB-47F8-4EC1-9BCB-F5B45605F0A8Q47194198-60025C74-B36E-4D25-97FD-399599843DFFQ47223964-E963C08B-578D-4741-BA31-6CC820A5F89CQ47323100-383BBB8F-E6BE-4DDD-81CF-E8E87883D912Q47618850-62F95F4E-204B-42BB-961A-51C504AEEE71Q51369618-1B60EB60-DD25-4262-A03F-D01A000EC0A0Q52381647-15AC5ED5-CD65-4A51-A636-266028EA52C4
P2860
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@en
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@nl
type
label
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@en
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@nl
prefLabel
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@en
Estimating the glomerular filtration rate in obese adult patients for drug dosing.
@nl
P1476
Estimating the glomerular filtration rate in obese adult patients for drug dosing
@en
P2093
Manjunath P Pai
P304
P356
10.1053/J.ACKD.2010.05.010
P577
2010-09-01T00:00:00Z